Pfizer appoints Pradip Shah as Chairman of Board EP News Bureau Feb 8, 2022 Pradip Shah succeeds R A Shah, who stepped down as Chairman
Alembic Pharma receives US FDA tentative approval for Fesoterodine Fumarate extended-release tablets EP News Bureau Feb 2, 2022 The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Toviaz extended-release…
EU drug regulator OKs Pfizer COVID pill for high-risk patients Reuters Jan 28, 2022 The endorsement by EMA for a conditional approval, if followed as usual by the European Commission, allows EU member states to…
Three doses of mRNA COVID vaccines very effective against Omicron and Delta: Study IANS Jan 24, 2022 The study, from the US Centers for Disease Control and Prevention (CDC), found that boosters of mRNA COVID vaccines are 82 per…
Pfizer shares in-vitro efficacy of novel COVID-19 oral treatment against Omicron EP News Bureau Jan 19, 2022 The in-vitro studies suggest that Paxlovid has the potential to maintain plasma concentrations many-fold times higher than the…
Fourth COVID vaccine partially effective against Omicron: Israeli study Press Trust of India Jan 19, 2022 The yet-to-be peer-reviewed study tested the efficacy and safety of vaccines and analysed whether the combination of vaccines from…
Pfizer to boost COVID-19 pill production with French deal Reuters Jan 18, 2022 The decision is part of Pfizer's strategy to boost global production of the pill, Paxlovid, which was found to be nearly 90 per…
US FDA approves drugs from AbbVie and Pfizer to treat eczema Reuters Jan 17, 2022 AbbVie’s Rinvoq and Pfizer’s Cibinqo have been approved to treat moderate-to-severe eczema, in patients who do not respond to…
Pfizer’s Prevnar 20 with Pfizer-BioNTech COVID-19 vaccine shows positive results in phase-III study EP News Bureau Jan 13, 2022 responses elicited by Prevnar 20 for all 20 serotypes were similar whether given with a dose of the Pfizer-BioNTech COVID-19…
WHO body says COVID-19 vaccines ‘may need to be updated’ for Omicron Reuters Jan 13, 2022 The technical group, made up of independent experts, said it would consider a change in vaccination composition and stressed that…